COVID-19 sent its dietary supplement sales soaring but a year on Bayer has been able to solidify those initial gains by its Nutritionals franchise.
While Nutritionals turnover only edged up by 0.6% - 4.7% adjusted for currency and portfolio effects – to €353m ($426m)...







